Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Dotton says what our CEO won't. They gave us some good quidance.

IMO, It is just the opposite. PTSC released it's opinion on the case thru Dutton. More to the point....Dutton relayed how TPL interpreted the results.

I do not think that Dutton was able to get patent lawyers opinions in just two days on how SC ruling would affect PTSC/TPL, now and in the long run.....especially if they were not well versed in the long history of the MMP. A legal opinion strong enough to make a public investment opinion on PTSC. Nah, I don't think so.

What we got thru Dutton was a suggestion from PTSC management and TPL lawyers that the SC decision IS not going to harm licensing efforts to the degree that the share price decline implied. I am good with this!

Share
New Message
Please login to post a reply